Literature DB >> 26691551

White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment.

Tanja Su1, Matthan W A Caan, Ferdinand W N M Wit, Judith Schouten, Gert J Geurtsen, James H Cole, David J Sharp, Frans M Vos, Maria Prins, Peter Portegies, Peter Reiss, Charles B Majoie.   

Abstract

OBJECTIVE: Cognitive impairment is highly prevalent in HIV-1-infected (HIV+) patients, despite adequate suppression of viral replication by combination antiretroviral therapy (cART). Cerebral white matter structure alterations are often associated with cognitive impairment and have commonly been reported in the natural course of HIV infection. However, the existence of these alterations in adequately treated HIV+ patients remains unknown, as well as its possible association with cognitive impairment.
DESIGN: We used diffusion tensor imaging (DTI) to investigate whether white matter structure alterations exist in HIV+ patients with sustained suppressed viral replication on cART, and if such alterations are related to HIV-associated cognitive deficits.
METHODS: We compared 100 aviraemic HIV+ men on cART with 70 HIV-uninfected, otherwise comparable men. Clinical and neuropsychological assessments were performed. From DTI data, white matter fractional anisotropy and mean diffusion were calculated. Subsequently, tract-based spatial statistics (TBSS) was performed, with and without masking out white matter lesions.
RESULTS: HIV+ patients showed diffuse white matter structure alterations as compared with HIV-uninfected controls, observed as widespread decreased fractional anisotropy and an increased mean diffusion. These white matter structure alterations were associated with the number of years spent with a CD4 cell count below 500 cells/μl, but not with HIV-associated cognitive deficits.
CONCLUSION: Cerebral white matter structure alterations are found in middle-aged HIV+ men with sustained suppression of viraemia on cART, and may result from periods with immune deficiency when viral toxicity and host-inflammatory responses were at their peak. These white matter structure alterations were not associated with the observed subtle HIV-associated cognitive deficits. VIDEO ABSTRACT: .

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26691551     DOI: 10.1097/QAD.0000000000000945

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  28 in total

Review 1.  Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.

Authors:  Benedetta Milanini; Victor Valcour
Journal:  Curr HIV/AIDS Rep       Date:  2017-08       Impact factor: 5.071

2.  HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition.

Authors:  Minjie Wu; Omalara Fatukasi; Shaolin Yang; Jeffery Alger; Peter B Barker; Hoby Hetherington; Tae Kim; Andrew Levine; Eileen Martin; Cynthia A Munro; Todd Parrish; Ann Ragin; Ned Sacktor; Eric Seaberg; James T Becker
Journal:  AIDS       Date:  2018-08-24       Impact factor: 4.177

Review 3.  The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.

Authors:  Vanessa Chilunda; Tina M Calderon; Pablo Martinez-Aguado; Joan W Berman
Journal:  Brain Res       Date:  2019-08-29       Impact factor: 3.252

4.  The Use of Visual Rating Scales to Quantify Brain MRI Lesions in Patients with HIV Infection.

Authors:  Jessica Robinson-Papp; Allison Navis; Mandip S Dhamoon; Uraina S Clark; Jose Gutierrez-Contreras; Susan Morgello
Journal:  J Neuroimaging       Date:  2017-08-21       Impact factor: 2.486

5.  Structural connectome differences in HIV infection: brain network segregation associated with nadir CD4 cell count.

Authors:  Ryan P Bell; Laura L Barnes; Sheri L Towe; Nan-Kuei Chen; Allen W Song; Christina S Meade
Journal:  J Neurovirol       Date:  2018-04-23       Impact factor: 2.643

Review 6.  HIV-associated neurocognitive disorder.

Authors:  David B Clifford
Journal:  Curr Opin Infect Dis       Date:  2017-02       Impact factor: 4.915

7.  The Effect of an HIV Self-Management Intervention on Neurocognitive Behavioral Processing.

Authors:  Allison R Webel; Nathaniel Schreiner; Robert A Salata; Jared Friedman; Anthony I Jack; Abdus Sattar; David M Fresco; Margaret Rodriguez; Shirley Moore
Journal:  West J Nurs Res       Date:  2019-01-17       Impact factor: 1.967

8.  White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.

Authors:  Lucette A Cysique; James R Soares; Guangqiang Geng; Maia Scarpetta; Kirsten Moffat; Michael Green; Bruce J Brew; Roland G Henry; Caroline Rae
Journal:  J Neurovirol       Date:  2017-03-21       Impact factor: 2.643

9.  Diffusion Basis Spectral Imaging Detects Ongoing Brain Inflammation in Virologically Well-Controlled HIV+ Patients.

Authors:  Jeremy F Strain; Tricia H Burdo; Sheng-Kwei Song; Peng Sun; Omar El-Ghazzawy; Brittany Nelson; Elizabeth Westerhaus; Laurie Baker; Florin Vaida; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-01       Impact factor: 3.731

Review 10.  Cognitive Impairment and Persistent CNS Injury in Treated HIV.

Authors:  Phillip Chan; Joanna Hellmuth; Serena Spudich; Victor Valcour
Journal:  Curr HIV/AIDS Rep       Date:  2016-08       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.